uniQure Gets Its Groove On: An Interview With CEO Jörn Aldag
Executive Summary
UniQure made history in 2012 for winning approval in the EU for the first gene therapy accepted by regulators in a major market. CEO Jörn Aldag shares his views on uniQure's ambitious expansion plans.